Simona Saluzzo, MD, PhD
Department of Dermatology
Medical University of Vienna
Gender and Equality Working Group
The goal of the Gender and Equality Working Group (GEWG) of the ÖGAI is to raise awareness on gender-related unconscious bias, promote equal career opportunities and increase the visibility of female immunologists and underrepresented groups in the Austrian scientific community. Our work is in accordance with the European Federation of Immunological Society’s (EFIS) Gender and Diversity Task Force. Our work is in accordance with the Gender and Diversity Task Force of the European Federation of Immunological Societies (EFIS).
Working group Spokesperson:
Simona Saluzzo, MD, PhD
MD, PhD Simona Saluzzo
Simona Saluzzo (ORCID 0000-0003-2675-4014) studied medicine at the University of Turin, Italy and performed her PhD in the laboratory of Prof. Sylvia Knapp at the Medical University of Vienna (MUW) and CeMM (Center for Molecular Medicine of the Austrian Academy of Science). She went on with her clinical training at Department of Dermatology of the MUW, and performed a postdoc in the laboratory of Ass-Prof. Georg Stary. She is currently working as a clinician devoting half of her working time for basic immunological research in skin anti-viral and anti-tumoral research. She is board member of the OEGAI since 2021.
Priv.-Doz. Dr.med.univ. Michael Bonelli
Michael Bonelli (ORCID 0000-0002-6122-7482) obtained his Medical Degree at the Medical University of Vienna, Austria and performed his postdoc in the laboratory of Dr. John O’Shea at the National Institute of Health. He is currently working as a principal investigator and rheumatologist at the Department of Rheumatology at the Medical University of Vienna. His laboratory is interested in the pathophysiology of immune-mediated inflammatory diseases. He is a board member of the OEGAI since 2021.
MSc Karoline Strobl
Karoline Strobl (ORCID 0009-0009-9771-3165) obtained her MSc degree at King’s College London in Biomedical and Molecular Sciences Research in 2019. There, she continued her work on regulatory T cells as a scientist in the laboratory of Prof. Alberto Sanchez-Fueyo, MD PhD at the Department of Inflammation Biology. Since 2020, she is working on her PhD in EGFR inhibitor-induced cutaneous adverse events in the laboratory of Thomas Bauer, PhD and Univ. Prof. Dr. Maria Sibilia at the Center for Cancer Research, Medical University of Vienna. She is a board member of the NGI since 2021 and a regular member of the OEGAI.